Post by
mikoola72 on Apr 05, 2014 6:03pm
Canexus mentioned on BNN April 4 Market Call
What some in the analyst community are thinking. Canexus Corp CUS-T Genevieve Roch-Decter (A Top Pick May 23/13. Down 43.1%.) Sold her holdings at around $6. This was a chemical company, paying out a high dividend and paying out most of their cash flow. They wanted to get into the “crude by rail” business and had to raise quite a bit of capital to do it. Had some cost overruns and part of their chemical business weakened. Management did a horrible job of communicating with the marketplace.
Comment by
Whatwasmyname on Apr 06, 2014 10:34am
Last bought deal $5.60. So let us say most recent valuation is $5.60 by market valuation by generally sharp participants at least. I say short term target is 19% plus 10% divs, thats almost 30%. I happen to also agree with Nawars calculations. He does his due diligence based on my expereience with him on LNV. Good luck fellas. I am in at 4.70 for 5000 shares full disclosure
Comment by
pm1231 on Apr 06, 2014 10:50am
secondary offering would have been offered at a discount to market value - so if bought deal was $5.6 - likely FMV was caculated closer to $5.9 to $6 per share - backing up my and Nawars calcs.